Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies.

Pinal-Fernandez I, Mecoli CA, Casal-Dominguez M, Pak K, Hosono Y, Huapaya J, Huang W, Albayda J, Tiniakou E, Paik JJ, Johnson C, Danoff SK, Corse AM, Christopher-Stine L, Mammen AL.

Neurology. 2019 Oct 8. pii: 10.1212/WNL.0000000000008443. doi: 10.1212/WNL.0000000000008443. [Epub ahead of print]

PMID:
31594859
2.

The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Solomon JJ, Danoff SK, Goldberg HJ, Woodhead F, Kolb M, Chambers DC, DiFranco D, Spino C, Haynes-Harp S, Hurwitz S, Peters EB, Dellaripa PF, Rosas IO; Trail Network.

Adv Ther. 2019 Sep 12. doi: 10.1007/s12325-019-01086-2. [Epub ahead of print]

PMID:
31515704
3.

Myositis Autoantibodies: A Comparison of Results from the Oklahoma Medical Research Foundation Myositis Panel to the Euroimmun Research Line Blot.

Mecoli CA, Casal-Dominguez M, Pak K, Pinal-Fernandez I, Albayda J, Tiniakou E, Paik JJ, Zahid U, Danoff SK, Mammen AL, Casciola-Rosen L, Christopher-Stine L.

Arthritis Rheumatol. 2019 Aug 20. doi: 10.1002/art.41088. [Epub ahead of print]

PMID:
31430029
4.

Interstitial Lung Disease in Polymyositis and Dermatomyositis.

Long K, Danoff SK.

Clin Chest Med. 2019 Sep;40(3):561-572. doi: 10.1016/j.ccm.2019.05.004. Review.

PMID:
31376891
5.

The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis.

Suresh K, Naidoo J, Zhong Q, Xiong Y, Mammen J, de Flores MV, Cappelli L, Balaji A, Palmer T, Forde PM, Anagnostou V, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Lin CT, Feller-Kopman D, Lerner AD, Lee H, Shafiq M, Yarmus L, Lipson EJ, Soloski M, Brahmer JR, Danoff SK, D'Alessio F.

J Clin Invest. 2019 Jul 16;130:4305-4315. doi: 10.1172/JCI128654.

6.

Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease.

Huapaya JA, Silhan L, Pinal-Fernandez I, Casal-Dominguez M, Johnson C, Albayda J, Paik JJ, Sanyal A, Mammen AL, Christopher-Stine L, Danoff SK.

Chest. 2019 Jun 22. pii: S0012-3692(19)31200-0. doi: 10.1016/j.chest.2019.05.023. [Epub ahead of print]

PMID:
31238042
7.

Collecting patient preference information using a Clinical Data Research Network: demonstrating feasibility with idiopathic pulmonary fibrosis.

Hollin IL, Dimmock AE, Bridges JF, Danoff SK, Bascom R.

Patient Prefer Adherence. 2019 May 16;13:795-804. doi: 10.2147/PPA.S201632. eCollection 2019.

8.

Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease.

Huapaya JA, Hallowell R, Silhan L, Pinal-Fernandez I, Casal-Dominguez M, Johnson C, Albayda J, Paik JJ, Lin CT, Hussien A, Mammen AL, Christopher-Stine L, Danoff SK.

Respir Med. 2019 Jul - Aug;154:6-11. doi: 10.1016/j.rmed.2019.05.012. Epub 2019 May 21.

PMID:
31176796
9.

Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndrome.

Casal-Dominguez M, Pinal-Fernandez I, Huapaya J, Albayda J, Paik JJ, Johnson C, Silhan L, Mammen AL, Danoff SK, Christopher-Stine L.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):858-861. Epub 2019 Apr 29.

10.

Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies.

Casal-Dominguez M, Pinal-Fernandez I, Corse AM, Paik J, Albayda J, Casciola-Rosen L, Johnson C, Danoff SK, Christopher-Stine L, Tiniakou E, Mammen AL.

Neurology. 2019 Mar 26;92(13):e1416-e1426. doi: 10.1212/WNL.0000000000007188. Epub 2019 Mar 1.

PMID:
30824556
11.

Sonographic findings from inflammatory arthritis due to antisynthetase syndrome.

Miller JB, Danoff SK, Bingham CO 3rd, Paik JJ, Mecoli CA, Tiniakou E, Christopher-Stine L, Albayda J.

Clin Rheumatol. 2019 May;38(5):1477-1483. doi: 10.1007/s10067-019-04471-y. Epub 2019 Feb 27.

PMID:
30810913
12.

Rebuttal From Drs Oldham and Danoff.

Oldham JM, Danoff SK.

Chest. 2019 Feb;155(2):264-265. doi: 10.1016/j.chest.2018.08.1071. No abstract available.

PMID:
30732690
13.

COUNTERPOINT: Does Interstitial Pneumonia With Autoimmune Features Represent a Distinct Class of Patients With Idiopathic Interstitial Pneumonia? No.

Oldham JM, Danoff SK.

Chest. 2019 Feb;155(2):260-263. doi: 10.1016/j.chest.2018.08.1073. No abstract available.

PMID:
30732688
14.

Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.

Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC.

QJM. 2019 Feb 1;112(2):81-93. doi: 10.1093/qjmed/hcy272. No abstract available.

PMID:
30605544
15.

Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.

Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC.

Arthritis Rheumatol. 2019 Feb;71(2):182-195. doi: 10.1002/art.40769. Epub 2019 Jan 3. No abstract available.

PMID:
30604506
16.

Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy.

Suresh K, Psoter KJ, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, Hales RK, D'Alessio F, Danoff SK, Naidoo J.

J Thorac Oncol. 2019 Mar;14(3):494-502. doi: 10.1016/j.jtho.2018.11.016. Epub 2018 Nov 30.

PMID:
30503891
17.

Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis.

Darrah E, Giles JT, Davis RL, Naik P, Wang H, Konig MF, Cappelli LC, Bingham CO 3rd, Danoff SK, Andrade F.

Front Immunol. 2018 Nov 20;9:2696. doi: 10.3389/fimmu.2018.02696. eCollection 2018.

18.

Risk factors for mortality and mortality rates in interstitial lung disease patients in the intensive care unit.

Huapaya JA, Wilfong EM, Harden CT, Brower RG, Danoff SK.

Eur Respir Rev. 2018 Nov 21;27(150). pii: 180061. doi: 10.1183/16000617.0061-2018. Print 2018 Dec 31.

19.

Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.

Suresh K, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, D'Alessio F, Hales RK, Lin CT, Psoter KJ, Danoff SK, Naidoo J.

J Thorac Oncol. 2018 Dec;13(12):1930-1939. doi: 10.1016/j.jtho.2018.08.2035. Epub 2018 Sep 26.

PMID:
30267842
20.

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal A, Galvin L, Inoue Y, Jenkins RG, Johkoh T, Kazerooni EA, Kitaichi M, Knight SL, Mansour G, Nicholson AG, Pipavath SNJ, Buendía-Roldán I, Selman M, Travis WD, Walsh S, Wilson KC; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society.

Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.

PMID:
30168753
21.

Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies.

De Lorenzo R, Pinal-Fernandez I, Huang W, Albayda J, Tiniakou E, Johnson C, Milisenda JC, Casal-Dominguez M, Corse AM, Danoff SK, Christopher-Stine L, Paik JJ, Mammen AL.

Neurology. 2018 Jun 5;90(23):e2068-e2076. doi: 10.1212/WNL.0000000000005638. Epub 2018 May 4.

22.

The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis.

Schiffenbauer A, Faghihi-Kashani S, O'Hanlon TP, Flegel WA, Adams SD, Targoff IN, Oddis CV, Ytterberg SR, Aggarwal R, Christopher-Stine L, Shamim EA, Dellaripa PF, Danoff SK, Mammen AL, Miller FW.

Semin Arthritis Rheum. 2018 Dec;48(3):504-512. doi: 10.1016/j.semarthrit.2018.02.003. Epub 2018 Feb 14.

PMID:
29703532
23.

Myositis: Prognostic factors in 'pneumo-myositis'.

Danoff SK.

Nat Rev Rheumatol. 2018 May;14(5):253-254. doi: 10.1038/nrrheum.2018.55. Epub 2018 Apr 12. No abstract available.

PMID:
29651120
24.

Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.

Johnson C, Rosen P, Lloyd T, Horton M, Christopher-Stine L, Oddis CV, Mammen AL, Danoff SK.

Respir Med. 2017 Sep;130:52-54. doi: 10.1016/j.rmed.2017.07.010. Epub 2017 Jul 17.

25.

A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.

Ryerson CJ, Corte TJ, Lee JS, Richeldi L, Walsh SLF, Myers JL, Behr J, Cottin V, Danoff SK, Flaherty KR, Lederer DJ, Lynch DA, Martinez FJ, Raghu G, Travis WD, Udwadia Z, Wells AU, Collard HR.

Am J Respir Crit Care Med. 2017 Nov 15;196(10):1249-1254. doi: 10.1164/rccm.201702-0400PP. No abstract available.

26.

"Hiker's feet": a novel cutaneous finding in the inflammatory myopathies.

Cox JT, Gullotti DM, Mecoli CA, Lahouti AH, Albayda J, Paik J, Johnson C, Danoff SK, Mammen AL, Christopher-Stine L.

Clin Rheumatol. 2017 Jul;36(7):1683-1686. doi: 10.1007/s10067-017-3598-5. Epub 2017 Apr 7. Review.

27.

A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.

Pinal-Fernandez I, Casal-Dominguez M, Huapaya JA, Albayda J, Paik JJ, Johnson C, Silhan L, Christopher-Stine L, Mammen AL, Danoff SK.

Rheumatology (Oxford). 2017 Jun 1;56(6):999-1007. doi: 10.1093/rheumatology/kex021.

28.

Toward understanding patient experience in idiopathic pulmonary fibrosis.

Danoff SK.

Eur Respir J. 2017 Jan 18;49(1). pii: 1602202. doi: 10.1183/13993003.02202-2016. Print 2017 Jan. No abstract available.

29.

Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients.

Albayda J, Pinal-Fernandez I, Huang W, Parks C, Paik J, Casciola-Rosen L, Danoff SK, Johnson C, Christopher-Stine L, Mammen AL.

Arthritis Care Res (Hoboken). 2017 Nov;69(11):1771-1776. doi: 10.1002/acr.23188.

30.

Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.

Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J, Paik JJ, Ahlawat S, Danoff SK, Lloyd TE, Mammen AL, Christopher-Stine L.

Ann Rheum Dis. 2017 Apr;76(4):681-687. doi: 10.1136/annrheumdis-2016-210198. Epub 2016 Sep 20.

31.

Intravenous Immunoglobulin as Potential Adjunct Therapy for Interstitial Lung Disease.

Hallowell RW, Amariei D, Danoff SK.

Ann Am Thorac Soc. 2016 Oct;13(10):1682-1688.

PMID:
27482830
32.

Statin-Induced Anti-HMGCR-Associated Myopathy.

Basharat P, Lahouti AH, Paik JJ, Albayda J, Pinal-Fernandez I, Bichile T, Lloyd TE, Danoff SK, Casciola-Rosen L, Mammen AL, Christopher-Stine L.

J Am Coll Cardiol. 2016 Jul 12;68(2):234-5. doi: 10.1016/j.jacc.2016.04.037. No abstract available.

33.

Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.

Pinal-Fernandez I, Parks C, Werner JL, Albayda J, Paik J, Danoff SK, Casciola-Rosen L, Christopher-Stine L, Mammen AL.

Arthritis Care Res (Hoboken). 2017 Feb;69(2):263-270. doi: 10.1002/acr.22920. Epub 2016 Dec 31.

34.

Smoking and Subclinical ILD in RA versus the Multi-Ethnic Study of Atherosclerosis.

Johnson C, Giles JT, Bathon J, Lederer D, Hoffman EA, Barr RG, Danoff SK.

PLoS One. 2016 Apr 6;11(4):e0153024. doi: 10.1371/journal.pone.0153024. eCollection 2016.

35.

Management of interstitial lung disease associated with connective tissue disease.

Mathai SC, Danoff SK.

BMJ. 2016 Feb 24;352:h6819. doi: 10.1136/bmj.h6819. Review.

PMID:
26912511
36.

Symptom-based management of the idiopathic interstitial pneumonia.

Garibaldi BT, Danoff SK.

Respirology. 2016 Nov;21(8):1357-1365. doi: 10.1111/resp.12649. Epub 2015 Oct 9. Review.

37.

Management of Idiopathic Pulmonary Fibrosis in the Elderly Patient: Addressing Key Questions.

Meyer KC, Danoff SK, Lancaster LH, Nathan SD.

Chest. 2015 Jul;148(1):242-252. doi: 10.1378/chest.14-2475. Review.

PMID:
26149553
38.

Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases.

Lloyd TE, Christopher-Stine L, Pinal-Fernandez I, Tiniakou E, Petri M, Baer A, Danoff SK, Pak K, Casciola-Rosen LA, Mammen AL.

Arthritis Care Res (Hoboken). 2016 Jan;68(1):66-71. doi: 10.1002/acr.22600.

39.

Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.

Johnson C, Connors GR, Oaks J, Han S, Truong A, Richardson B, Lechtzin N, Mammen AL, Casciola-Rosen L, Christopher-Stine L, Danoff SK.

Respir Med. 2014 Oct;108(10):1542-8. doi: 10.1016/j.rmed.2014.09.003. Epub 2014 Sep 18.

40.

Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances.

Hallowell RW, Danoff SK.

Curr Opin Rheumatol. 2014 Nov;26(6):684-9. doi: 10.1097/BOR.0000000000000104. Review.

PMID:
25203119
41.

Lung transplantation in telomerase mutation carriers with pulmonary fibrosis.

Silhan LL, Shah PD, Chambers DC, Snyder LD, Riise GC, Wagner CL, Hellström-Lindberg E, Orens JB, Mewton JF, Danoff SK, Arcasoy MO, Armanios M.

Eur Respir J. 2014 Jul;44(1):178-87. doi: 10.1183/09031936.00060014. Epub 2014 May 15.

42.

Pulmonary manifestations of polymyositis/dermatomyositis.

Hallowell RW, Ascherman DP, Danoff SK.

Semin Respir Crit Care Med. 2014 Apr;35(2):239-48. doi: 10.1055/s-0034-1371528. Epub 2014 Mar 25. Review.

PMID:
24668538
43.

A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease.

Doyle TJ, Lee JS, Dellaripa PF, Lederer JA, Matteson EL, Fischer A, Ascherman DP, Glassberg MK, Ryu JH, Danoff SK, Brown KK, Collard HR, Rosas IO.

Chest. 2014 Mar 1;145(3):454-463. doi: 10.1378/chest.13-2408. Review.

44.

Role of support measures and palliative care.

Danoff SK, Schonhoft EH.

Curr Opin Pulm Med. 2013 Sep;19(5):480-4. doi: 10.1097/MCP.0b013e328363f4cb. Review.

PMID:
23880699
45.

Pulmonary manifestations of Sjögren's syndrome.

Stojan G, Baer AN, Danoff SK.

Curr Allergy Asthma Rep. 2013 Aug;13(4):354-60. Review.

46.

Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.

Giles JT, Danoff SK, Sokolove J, Wagner CA, Winchester R, Pappas DA, Siegelman S, Connors G, Robinson WH, Bathon JM.

Ann Rheum Dis. 2014 Aug;73(8):1487-94. doi: 10.1136/annrheumdis-2012-203160. Epub 2013 May 28.

47.

Pulmonary impairment, not muscle injury, is associated with elevated ESR in the idiopathic inflammatory myopathies.

Park JK, Gelber AC, George M, Danoff SK, Qubti MA, Christopher-Stine L.

Rheumatology (Oxford). 2013 Jul;52(7):1336-8. doi: 10.1093/rheumatology/ket162. Epub 2013 Apr 24. No abstract available.

48.

Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.

Hall JC, Casciola-Rosen L, Samedy LA, Werner J, Owoyemi K, Danoff SK, Christopher-Stine L.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1307-15. doi: 10.1002/acr.21992.

49.

Bronchiolitis.

Garibaldi BT, Illei P, Danoff SK.

Immunol Allergy Clin North Am. 2012 Nov;32(4):601-19. doi: 10.1016/j.iac.2012.08.002. Epub 2012 Sep 14. Review.

PMID:
23102068
50.

Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial.

Horton MR, Santopietro V, Mathew L, Horton KM, Polito AJ, Liu MC, Danoff SK, Lechtzin N.

Ann Intern Med. 2012 Sep 18;157(6):398-406. doi: 10.7326/0003-4819-157-6-201209180-00003.

PMID:
22986377

Supplemental Content

Loading ...
Support Center